An interventional trial assessing the tolerability and safety of GRAZAX® in adults with grass pollen allergy. [EXTENSION OF 700013013]

Trial Profile

An interventional trial assessing the tolerability and safety of GRAZAX® in adults with grass pollen allergy. [EXTENSION OF 700013013]

Completed
Phase of Trial: Phase IV

Latest Information Update: 20 Mar 2014

At a glance

  • Drugs Grass pollen allergy immunotherapy (Primary)
  • Indications Grass pollen hypersensitivity; Rhinoconjunctivitis; Seasonal allergic rhinitis
  • Focus Adverse reactions
  • Sponsors ALK-Abello
  • Most Recent Events

    • 20 Mar 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top